An efficient anticancer histone deacetylase inhibitor and its analogues for human HDAC8

[1]  Yong-Jun Jiang,et al.  3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment. , 2009, European journal of medicinal chemistry.

[2]  Yadong Chen,et al.  Pharmacophore Identification of Hydroxamate HDAC 1 Inhibitors , 2009 .

[3]  K. Yelekçi,et al.  Histone Deacetylase Inhibition Activity and Molecular Docking of (E )‐Resveratrol: Its Therapeutic Potential in Spinal Muscular Atrophy , 2009, Chemical biology & drug design.

[4]  Xiang-Jiao Yang,et al.  Histone deacetylase inhibitors as novel anticancer therapeutics , 2008, Current oncology.

[5]  G. Kouraklis,et al.  Histone deacetylase inhibitors as a potential therapeutic agent for human cancer treatment , 2006, Targeted Oncology.

[6]  J. Fang.  Histone deacetylase inhibitors, anticancerous mechanism and therapy for gastrointestinal cancers , 2005, Journal of gastroenterology and hepatology.

[7]  C. Monneret.  Histone deacetylase inhibitors. , 2005, European journal of medicinal chemistry.

[8]  R. De Francesco,et al.  Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. R. Somoza,et al.  Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. , 2004, Structure.

[10]  K. Garber.  Purchase of Aton spotlights HDAC inhibitors , 2004, Nature Biotechnology.

[11]  반에멜렌크리스토프,et al.  Inhibitors of histone deacetylase , 2003 .

[12]  G. Gores,et al.  Calpains Can Do It Alone: Implications for Cancer Therapy , 2003, Cancer biology & therapy.

[13]  K. Glaser,et al.  Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. , 2003, Molecular cancer therapeutics.

[14]  Daniel Delorme,et al.  Structurally simple trichostatin A-like straight chain hydroxamates as potent histone deacetylase inhibitors. , 2002, Journal of medicinal chemistry.

[15]  Manfred Jung,et al.  Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates. , 2002, Journal of medicinal chemistry.

[16]  S. Leit,et al.  Design and synthesis of a novel class of histone deacetylase inhibitors. , 2001, Bioorganic & medicinal chemistry letters.

[17]  A. Mai,et al.  3-(4-aroyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides, a new class of synthetic histone deacetylase inhibitors. , 2001, Journal of medicinal chemistry.

[18]  P. Marks,et al.  Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors , 1999, Nature.

[19]  M F Sanner,et al.  Python: a programming language for software integration and development. , 1999, Journal of molecular graphics & modelling.

[20]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[21]  Minoru Yoshida,et al.  [Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A]. , 1990, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[22]  J. Gasteiger,et al.  ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .